Health ❯ Chronic Conditions ❯ Obesity

Treatment Options

Injectable Medications Oral Medications Patient Outcomes Novo Nordisk Zepbound Wegovy Ozempic Lifestyle Changes Patient Demographics GLP-1 Receptor Agonists Patient Testimonials GLP-1 Drugs GLP-1 Therapy Medication Management Patient Experiences Patient Preferences Weight Loss Medications GLP-1 Medications

Lilly Launches FDA-Cleared Monthly Zepbound KwikPen on LillyDirect at $299 Starter Price

The direct-to-consumer launch targets self-pay patients at a $299 starter price to expand choice.

Lilly's Rally Deepens as U.S. Access Deal Recasts Outlook for GLP‑1 Drugs

White House Clinches GLP-1 Price Deal as Lilly Sets Zepbound and Pill Pricing